BD (NYSE:BDX) today announced the introduction of the Elyra thulium fiber laser (TFL) system for treating kidney stones.
Becton Dickinson expects to achieve currency-neutral revenue growth in the low single-digit range for the current fiscal year ...
In early May 2026, Becton, Dickinson and Company reported higher quarterly sales of US$4.71 billion but swung to a net loss, raised its full-year adjusted earnings guidance, completed the divestiture ...
After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest its diagnostic and biosciences businesses as the company nears the finish ...
Zacks Investment Research on MSN
BD launches Elyra thulium fiber laser system for kidney stone care
Becton, Dickinson and Company BDX, popularly known as BD, recently announced the launch of the Elyra Thulium Fiber Laser (TFL ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced results for its fiscal 2026 second quarter, which ended March 31, 2026.
BD (Becton, Dickinson and Company) has agreed to combine its biosciences and diagnostic solutions business with Waters Corporation, creating a new life science and diagnostics company. The agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results